These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33043046)

  • 1. Respiratory dysfunction in Parkinson's disease: a narrative review.
    D'Arrigo A; Floro S; Bartesaghi F; Casellato C; Sferrazza Papa GF; Centanni S; Priori A; Bocci T
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33043046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory Dysfunctions in Parkinson's Disease Patients.
    Docu Axelerad A; Stroe AZ; Arghir OC; Docu Axelerad D; Gogu AE
    Brain Sci; 2021 May; 11(5):. PubMed ID: 34064360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory dysfunction in Parkinson's disease.
    Torsney KM; Forsyth D
    J R Coll Physicians Edinb; 2017 Mar; 47(1):35-39. PubMed ID: 28569280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts.
    Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M
    Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal dysfunction in idiopathic Parkinsonism: A narrative review.
    Salari M; Fayyazi E; Mirmosayyeb O
    J Res Med Sci; 2016; 21():126. PubMed ID: 28331512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyspnea in Parkinson's disease.
    Jain S; Patel S; Nugent K
    Respir Med; 2024 Sep; 234():107801. PubMed ID: 39251095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C9ORF72 intermediate repeat expansion in patients affected by atypical parkinsonian syndromes or Parkinson's disease complicated by psychosis or dementia in a Sardinian population.
    Cannas A; Solla P; Borghero G; Floris GL; Chio A; Mascia MM; Modugno N; Muroni A; Orofino G; Di Stefano F; Calvo A; Moglia C; Restagno G; Meloni M; Farris R; Ciaccio D; Puddu R; Vacca MI; Melis R; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Marrosu MG; Marrosu F
    J Neurol; 2015 Nov; 262(11):2498-503. PubMed ID: 26275564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we irradiate a brain tumor in a patient with parkinsonism? A case report and literature review.
    Engelman A; Perumal K; Mehta M
    Pract Radiat Oncol; 2015; 5(4):e327-35. PubMed ID: 25659287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory disturbances in a mouse model of Parkinson's disease.
    Oliveira LM; Oliveira MA; Moriya HT; Moreira TS; Takakura AC
    Exp Physiol; 2019 May; 104(5):729-739. PubMed ID: 30758090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory dysfunction in Parkinson's disease.
    Brown LK
    Clin Chest Med; 1994 Dec; 15(4):715-27. PubMed ID: 7867286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
    Miraglia F; Betti L; Palego L; Giannaccini G
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 33: the history of movement disorders.
    Lanska DJ
    Handb Clin Neurol; 2010; 95():501-46. PubMed ID: 19892136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's Disease and Cognitive Impairment.
    Yang Y; Tang BS; Guo JF
    Parkinsons Dis; 2016; 2016():6734678. PubMed ID: 28058128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MAG autoantibodies are increased in Parkinson's disease but not in atypical parkinsonism.
    Papuć E; Rejdak K
    J Neural Transm (Vienna); 2017 Feb; 124(2):209-216. PubMed ID: 27766424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Selective stimulations and lesions of the rat brain nuclei as the models for research of the human sleep pathology mechanisms].
    Šaponjić J
    Glas Srp Akad Nauka Med; 2011; (51):85-97. PubMed ID: 22165729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S; Constantinescu R; Zetterberg H; Andreasson U; Holmberg B; Jeromin A
    Parkinsonism Relat Disord; 2014 Apr; 20(4):382-7. PubMed ID: 24507721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive and restrictive pulmonary dysfunction increases disability in Parkinson disease.
    Sabaté M; Rodríguez M; Méndez E; Enríquez E; González I
    Arch Phys Med Rehabil; 1996 Jan; 77(1):29-34. PubMed ID: 8554470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive and restrictive pulmonary dysfunctions in Parkinson's disease.
    Sabaté M; González I; Ruperez F; Rodríguez M
    J Neurol Sci; 1996 Jun; 138(1-2):114-9. PubMed ID: 8791248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.